The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Interventions for valvular disease and heart failure
Valvular heart interventions: advances from 2019 to 2020
Rutao Wang1,2,3,4, MD; Chao Gao1,2,3,4, MD; Hideyuki Kawashima1,2,5, MD; Rodrigo Modolo6, MD; Liesbeth Rosseel1,2, MD; Yoshinobu Onuma1,2, MD, PhD; Osama Soliman1,2, MD, PhD; Patrick W. Serruys1,2,7, MD, PhD; Darren Mylotte1,2, MBBCh, MD, PhD
1. Department of Cardiology, National University of Ireland, Galway (NUIG), Galway, Ireland; 2. Department of Cardiology, Xijing Hospital, Xi’an, China; 3. Department of Cardiology, Radboud University, Nijmegen, the Netherlands; 4. CORRIB Research Center for Advanced Imaging and Core Lab, Galway, Ireland; 5. Department of Cardiology, Amsterdam University Medical Center, Amsterdam, the Netherlands; 6. Department of Internal Medicine, Cardiology Division, University of Campinas (UNICAMP), Campinas, SP, Brazil; 7. NHLI, Imperial College London, London, United Kingdom
Introduction
Percutaneous valve technologies have revolutionised the treatment of valvular heart disease (VHD) and emerged as an alternative treatment option in elderly patients at all levels of surgical risk. In 2019 and 2020, important advances in the field of valvular heart interventions were achieved. In this review, we present the most recent and relevant studies that have emerged on the transcatheter treatment of VHD in 2019 and 2020.
AORTIC STENOSIS
In August 2019, the U.S. Food and Drug Administration (FDA) approved the use of transcatheter aortic valve replacement (TAVR) for the treatment of symptomatic severe aortic stenosis (AS) in low-risk ...
Sign in to read and download the full article
Forgot your password? No account yet?
Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
aortic stenosismitral regurgitationparavalvular leaktavitricuspid diseasettvr
Interventions for valvular diseaseTAVIMitral valve replacement and repairTricuspid / Pulmonary valve
Read next article
Transcatheter edge-to-edge mitral valve repair with the PASCAL system: early results from a real-world series